A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia-Reference-Cited by-同舟云学术

A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia

Published:2019-02-08 Issue:2 Volume:60 Page:624
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Hsu Cherng-Ru¹,Chen Yi-Hsun²³,Liu Chih-Peng²,Chen Chih-Hung²,Huang Kuo-Kuei²⁴,Huang Jui-Wen²,Lin Meng-Nan²,Lin Chih-Lung²,Chen Wan-Ru²,Hsu Yi-Ling²,Lee Tze-chung²,Chou Shuen-Hsiang²,Tu Chia-Mu²,Hwang Chrong-Shiong²,Huang Yu Chuan⁵,Lu Da-Wen¹

Affiliation:

1. Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China

2. Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu, Republic of China

3. Institute of Nanoengineering and Microsystems, National Tsing Hua University, Hsinchu, Republic of China

4. Institue of Biotechnology, National Tsing Hua University, Hsinchu, Republic of China

5. Department of Research and Development, National Defense Medical Center, Taipei, Republic of China

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the ROCK/MYLK Pathway Affects Complex Molecular and Morphological Changes of the Trabecular Meshwork Associated With Ocular Hypertension;Investigative Ophthalmology & Visual Science;2024-08-08

2. Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment;Russian Ophthalmological Journal;2024-07-02

3. The Application of Rho Kinase Inhibitors in the Management of Glaucoma;International Journal of Molecular Sciences;2024-05-21

4. ROCK inhibitor: Focus on recent updates;Chinese Chemical Letters;2023-12

5. Identifying new drugs and targets to treat rapidly elevated intraocular pressure for angle closure and secondary glaucomas to curb visual impairment and prevent blindness;Experimental Eye Research;2023-07